MedTrace Logo

Evaluation and Validation of New Biomarkers by Mass Spectrometry

NCT01025973 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2018-05-08

No results posted yet for this study

Summary

The investigators will perform biochemical and metabolic evaluations on cord blood, venous blood of the mother and urine of the foetus and mother using time-of-flight and tandem mass spectrometry. The investigators could evaluate, dose and validate gestational diabetes mellitus biomarkers of the fetus and mother.

Conditions

Sponsors & Collaborators

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Jean-Luc Ardilouze, MD, PhD · Université de Sherbrooke

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-05-31
Completion
2013-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01025973 on ClinicalTrials.gov